Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.
The British Association for Psychopharmacology (BAP) coordinated a meeting of experts to review the evidence on the drug treatment for dementia. The level of evidence (types) was rated using a standard system: Types 1a and 1b (evidence from meta-analysis of randomised controlled trials or at least o...
Main Authors: | Burns, A, O'Brien, J, Auriacombe, S, Ballard, C, Broich, K, Bullock, R, Feldman, H, Ford, G, Knapp, M, McCaddon, A, Iliffe, S, Jacova, C, Jones, R, Lennon, S, McKeith, I, Orgogozo, J, Purandare, N, Richardson, M, Ritchie, C, Thomas, A, Warner, J, Wilcock, G, Wilkinson, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Homocysteine and dementia – an international consensus statement
by: Smith, DA, et al.
Published: (2018) -
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.
by: Wilson, S, et al.
Published: (2010) -
No psychiatry without psychopharmacology.
by: Harrison, P, et al.
Published: (2011) -
PRIMATE MODELS IN PSYCHOPHARMACOLOGY
by: Rupniak, N, et al.
Published: (1988) -
Psychopharmacology of moral and social judgments
by: Terbeck, S
Published: (2012)